Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.
about
The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkersNEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertensionMethodological considerations in quantification of oncological FDG PET studies.Partial volume correction strategies for quantitative FDG PET in oncology.Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.Positron Emission Tomography (PET) in OncologyMolecular imaging of gene expression and protein function in vivo with PET and SPECT.Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?The potential of positron-emission tomography to study anticancer-drug resistance.Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer.Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PETQuantitative techniques in 18FDG PET scanning in oncology.Overview of early response assessment in lymphoma with FDG-PET.18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetesVariation in urinary excretion of FDG, yet another uncertainty in quantitative PET.Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers.First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in manMethodology for quantitative rapid multi-tracer PET tumor characterizationsWhat is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.Speeding up PET/MR for cancer staging of children and young adults.Multivariate analysis of various factors affecting background liver and mediastinal standardized uptake values.Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.Role of 18FDG-positron emission tomography scanning in the management of histiocytosis.Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.Radiopharmaceuticals in monitoring cancer.Definitive chemoirradiation for resectable head and neck cancer: treatment outcome and prognostic significance of MRI findings.Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom.Prognostic value of pre-treatment 18F-FDG PET uptake for nasopharyngeal carcinoma.Voxel clustering for quantifying PET-based treatment response assessment.Matching PET and CT scans of the head and neck area: development of method and validation.Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?Variations of the liver standardized uptake value in relation to background blood metabolism: An 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography study in a large population from China.Solid-Phase Synthesis of Fluorinated Analogues of Glycosyl 1-Phosphate Repeating Structures from Leishmania using the Phosphoramidite Method.
P2860
Q28608269-1CA3A5BF-B2F9-49CB-8F7F-D99A3087F639Q33356751-1B27C7F6-D938-4508-80EE-1B23A2A217A5Q33670824-8A7450FE-B081-4A50-8DC5-E45DA2A895AFQ33806143-7BD937AB-5D38-4BD8-8DE6-19E3FA603320Q33915164-82BAAA0B-8448-4B96-9923-7687DA063387Q34054615-14216EF0-2AE2-4CC0-9AA0-5339DBE2E76FQ34757048-99A21619-3C74-4219-8FC5-3D260F601DFCQ34774840-8E8A8254-10A8-416A-A2D2-BCFA75482A42Q34918519-A46E06CA-07D8-48FB-825E-C28315045857Q35605032-131C2436-2CCF-4027-96F9-4273EF4D4BD3Q35788120-C77945E5-B71D-44E1-BAA8-4B08476EF6A7Q36143593-C0EE8725-254A-4435-A095-8D8AF9C85AF3Q36382036-5B11FF1F-DFE5-456D-8173-60314F4A3DE9Q36454757-53937EAA-EE16-41BF-83ED-36C078B02D7AQ36667512-1E0EA4D8-7D1F-4C2C-9E20-A39A4D4F8917Q36927213-0AE04AF9-E45B-4752-BAFB-0F4130EC7FF7Q37016566-8A7D67FA-424B-479C-899E-5D6EAC09A5E9Q37031004-9CD4D13E-5B94-4AAF-95B9-23CD4FA1D11DQ37082572-9CA7BEF7-BB05-4FF6-9000-7654B4931005Q37197913-E5C00CC4-3159-4B9F-A80D-7C3BF5702727Q37220932-BC8810F5-DBA7-40AF-9BF0-12CB8912F5F6Q37342653-9AD52E95-D943-4F58-9BB8-52201C674261Q37424511-0B550BA5-B2CA-4645-899E-129B7594FAFFQ38641832-29030BB4-927F-4833-96CC-B502FC2623CEQ39860692-4DFAC383-1580-40F1-9289-11C78138BAF9Q39892814-2F57BDAC-A756-4C18-A1E4-F24836A1A0FBQ40481759-9DB644D5-8309-49CF-A187-361B3E92A7EFQ40840134-66A5CD47-3E12-4359-A3E7-D20DFF38E9F9Q43916705-A711F370-63B1-4278-A37D-1EAC60C7FD3AQ44281597-CB0D0CF2-898E-48B4-AE69-87205F9C21A5Q44756080-DFB239E2-1290-4227-BECB-0F9AA97A85B1Q46346700-F460F13E-BACD-4E89-9016-B9DDFFBE1B5DQ46589781-8DA74D8C-D052-4190-80CA-D4BC01718243Q47655837-3708C6AF-6EA1-43AA-9CBE-3FDFD2ABCB8FQ49607757-F8F53142-70A6-467E-8959-0FB85DF13816Q50920033-E812A703-8B81-4AE4-BBE1-695AF1DB8CC6Q52029438-DD8A8C28-7152-4BD4-B232-1867ED8ABEF5Q53014495-02501536-A73B-4C95-BA9F-E3C959E1B384Q54984593-34A69045-1F9C-4485-AAF8-ABC18D0C99BAQ55222446-32335B07-9C91-4544-8248-7E8325856A72
P2860
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Monitoring response to therapy ...... different analytical methods.
@ast
Monitoring response to therapy ...... different analytical methods.
@en
type
label
Monitoring response to therapy ...... different analytical methods.
@ast
Monitoring response to therapy ...... different analytical methods.
@en
prefLabel
Monitoring response to therapy ...... different analytical methods.
@ast
Monitoring response to therapy ...... different analytical methods.
@en
P2093
P356
P1476
Monitoring response to therapy ...... different analytical methods.
@en
P2093
Hoekstra CJ
Hoekstra OS
Lammertsma AA
Paglianiti I
Postmus PE
P2888
P304
P356
10.1007/S002590050570
P577
2000-06-01T00:00:00Z